Browse Viral antibodies topic

Health aspects subtopic

Articles 1-28 out of 28 article(s) Title Author Type Date Words Morphotek(R), Inc. Receives $1.7M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Microbial Bioweapons. Jun 23, 2008 694 Antibody politics: the treatment of incurable HIV/Aids patients in the developing world takes too big a slice of a limited budget when money could be better spent on protecting people from both HIV and other preventable fatal diseases. Cassell, Merrill Mar 1, 2008 926 Exposure to novel parainfluenza virus and clinical relevance in 2 bottlenose dolphin (Tursiops truncatus) populations. Venn-Watson, Stephanie; Rivera, Rebecca; Smith, Cynthia R.; Saliki, Jeremiah T.; Caseltine, Shannon; Mar 1, 2008 6031 Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Hinjoy, Soawapak; Puthavathana, Pilaipan; Laosiritaworn, Yongjua; Limpakarnjanarat, Khanchit; Pooruk Mar 1, 2008 1960 Swine workers and swine influenza virus infections. Gray, Gregory C.; McCarthy, Troy; Capuano, Ana W.; Setterquist, Sharon F.; Olsen, Christopher W.; Al Clinical report Dec 1, 2007 6209 Seroconversion in wild birds and local circulation of West Nile virus, Spain. Figuerola, Jordi; Soriguer, Ramon; Rojo, Gema; Tejedor, Concepcion Gomez; Jimenez-Clavero, Miguel An Dec 1, 2007 1915 Plexera Bioscience Announces Agreement with Leading Therapeutic Antibody Company. Nov 13, 2007 509 Zymeworks Inc. Announces Collaborative Research Agreements for Computational Antibody Modeling and the Development of Tuberculosis Therapeutic Agents. Oct 31, 2007 713 Morphotek Receives $2.7M in Funding from the National Institute of Allergy and Infectious Diseases to Develop Therapeutic Antibodies Against Biowarfare Agents. Oct 3, 2007 757 Morphotek Receives $2.3M in Funding from the U.S. Department of Defense to Develop Therapeutic Antibodies Against Biowarfare Agents. Sep 19, 2007 645 Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies. Sep 5, 2007 790 U.S. vaccine against bird flu approved. Arias, Donya C. Brief article Jun 1, 2007 277 Hantavirus and arenavirus antibodies in persons with occupational rodent exposure, North America. Ksiazek, Thomas G. Apr 1, 2007 5461 Cell Signaling Technology Announces Alliance with Merck to Provide PhosphoScan(R) Proteomics & Antibody Development for Biomarker Discovery to Support Oncology Therapeutic Programs. Mar 28, 2007 299 Dyax Corp. and Glenmark Enter Into Funded Research Agreement for Discovery of Therapeutic Antibodies. Mar 12, 2007 1143 Dyax and ZymoGenetics Enter Into Library License Agreement for Discovery of Therapeutic Antibodies. Oct 31, 2006 695 FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer. Sep 27, 2006 1585 Affitech to Play Key Role in Major EU Embryonal Tumor Pipeline Project; Proprietary Discovery Platforms to Be Utilized to Identify Fully Human Therapeutic Antibody Candidates. Sep 12, 2006 460 Dyax Corp. and Serono Enter Into Library License and Funded Research Agreements for Discovery of Therapeutic Antibodies. Sep 7, 2006 722 Peregrine's phospholipid-targeted antibodies fused wth cytokines reduce tumor growth. Sep 1, 2006 629 Celera Genomics and Medarex Establish Therapeutic Antibody Collaboration in Cancer; Collaboration Combines Celera's Protein Discoveries with Medarex's Expertise in Developing Fully Human Antibody Therapeutics. Jun 22, 2006 1304 Alfacell announces new research collaboration to develop next-generation targeted therapies for cancer. Jun 1, 2006 526 XOMA and Schering-Plough Establish Collaboration for Therapeutic Antibody Discovery and Development. May 23, 2006 576 Dyax Corp. and ICOS Corporation Enter Into License Agreement for Discovery of Therapeutic Antibodies. May 22, 2006 696 XOMA Establishes Development and Manufacturing Relationship with Taligen; XOMA to utilize its Bacterial Cell Expression Technology to Manufacture Novel Anti-Inflammatory Therapeutic for Clinical Trials. May 17, 2006 787 BioInvent and Immusol to Collaborate on Antibody Therapeutic for Macular Degeneration. Apr 3, 2006 613 Caprion's caStx 1-2 Antibodies Receive European and US Orphan Drug Designation for Treatment of Shiga-Toxin Producing E. Coli. Dec 20, 2005 487 Cell Genesys reports potential breakthrough in antibody production technology. Apr 1, 2005 591